|
|
41
|
|
|
4181S
|
|
|
ACCENTRIX 10MG/ML INJ (NVS) RANIBIZUMAB (C)
|
|
|
RANIBIZUMAB
|
|
|
ACCENTRIX
|
|
|
1 DOSE
|
|
|
C
|
|
|
788.31
|
|
|
788.314
|
|
|
10MG/ML
|
|
|
VIAL
|
|
|
0
|
|
|
VIAL
|
|
|
NVS
|
|
|
NOVARTIS CARIBE SA
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
|
|
|
|
|
|
2024-04-01
|
|
|
2026-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
|